THERAPY FROM A CRITICAL VIEWPOINT
Discontinue beta-blockers after myocardial infarction without cardiac failure?
NEW ON THE MARKET
High-dose aflibercept (EYLEA) for macular degeneration/diabetic macular edema
a-t READERS QUESTIONS AND COMMENTS
Recommendation of the German Standing Committee on Vaccination (STIKO): meningococcal B vaccine (BEXSERO) for infants
IN BRIEF
Stress ulcer prophylaxis during ventilation: less bleeding, but no effect on mortality
Unexpected pregnancies with semaglutide (OZEMPIC, WEGOVY) and tirzepatide (MOUNJARO)
Early detection of familial hypercholesterinaemia: IQWiG favours cascade screening
Intravenous iron: clarification by the company Vifor on FERINJECT and the competitor product MONOFER
Multivitamins without effect on mortality
Gender marketing: BUSCOPAN PLUS in pink free article
SIDE EFFECTS
Liver damage with fezolinetant (VEOZA)
e a-t ON THE INTERNET
Patent thickets for original preparations hinder the market introduction of generics